Literature DB >> 33672913

Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period.

Gyorgy Jermendy1, Agnes Kecskes2, Attila Nagy2.   

Abstract

Background and
Objectives: In patients with diabetes mellitus, hypoglycaemic episodes, especially during night hours, carry a significant risk. Data about the occurrence of nocturnal hypoglycaemia in real-world settings are of clinical importance. The aim of our study was to evaluate the occurrence of nocturnal hypoglycaemia among patients with diabetes using self-monitoring of blood glucose (SMBG) with telemedicine support. Materials and
Methods: We retrospectively analysed the central database of an internet-based supportive system between 2010 and 2020 when 8190 SMBG users uploaded nearly 10 million capillary blood glucose values. Nocturnal hypoglycaemia was defined as capillary blood glucose < 3.0 mmol/L measured between 00:00 and 05:59 h.
Results: The database contained 914,146 nocturnal blood glucose values from 7298 users; 24,623 (2.7%) glucose values were below the hypoglycaemic threshold and 2363 patients (32.4%) had at least one hypoglycaemic glucose value. Nocturnal hypoglycaemia was more often found in patients with type 1 vs. type 2 diabetes (n = 1890 (80.0%) vs. n = 387 (16.4%), respectively). Hypoglycaemic blood glucose values were most frequently observed in the age group of 10.0-19.9 years (n = 481 (20.4%)). Patients with nocturnal hypoglycaemia were mostly on insulin treatment (1854 (78.5%) patients with 20,727 (84.1%) hypoglycaemic glucose values). Only 356 patients (15.1%) with nocturnal hypoglycaemia performed a retest within 120 min. Within a one-day-long (1440 min) timeframe, the elapsed median time until a retest, yielding a safe blood glucose value (>3.9 mml/L), was 273 min (interquartile range: 157-300 min). Conclusions: Nocturnal hypoglycaemia should be considered as a persisting challenge to antihyperglycaemic treatment in patients living with diabetes. Continuous efforts are needed to improve both antihyperglycaemic treatment and patient education for preventing nocturnal hypoglycaemia, and to act adequately if hypoglycaemic values are detected.

Entities:  

Keywords:  diabetes management; health hazard; hypoglycaemia; real-world data

Mesh:

Substances:

Year:  2021        PMID: 33672913      PMCID: PMC7918473          DOI: 10.3390/medicina57020167

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  45 in total

1.  Emergency hospitalizations for adverse drug events in older Americans.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Nadine Shehab; Chesley L Richards
Journal:  N Engl J Med       Date:  2011-11-24       Impact factor: 91.245

Review 2.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

Review 3.  Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?

Authors:  Melanie J Davies; Cristina Bianchi; Stefano Del Prato
Journal:  Metabolism       Date:  2020-04-18       Impact factor: 8.694

Review 4.  Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic review.

Authors:  Hugh D Tildesley; Michelle D Po; Stuart A Ross
Journal:  Med Clin North Am       Date:  2014-10-18       Impact factor: 5.456

5.  New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).

Authors:  Philip D Home; Richard M Bergenstal; Geremia B Bolli; Monika Ziemen; Maria Rojeski; Melanie Espinasse; Matthew C Riddle
Journal:  Diabetes Care       Date:  2015-06-17       Impact factor: 19.112

6.  Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system.

Authors:  Robert J Tanenberg; Christopher A Newton; Almond J Drake
Journal:  Endocr Pract       Date:  2010 Mar-Apr       Impact factor: 3.443

7.  Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited.

Authors:  G V Gill; A Woodward; I F Casson; P J Weston
Journal:  Diabetologia       Date:  2008-10-30       Impact factor: 10.122

Review 8.  Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.

Authors:  Richard D Feinman; Wendy K Pogozelski; Arne Astrup; Richard K Bernstein; Eugene J Fine; Eric C Westman; Anthony Accurso; Lynda Frassetto; Barbara A Gower; Samy I McFarlane; Jörgen Vesti Nielsen; Thure Krarup; Laura Saslow; Karl S Roth; Mary C Vernon; Jeff S Volek; Gilbert B Wilshire; Annika Dahlqvist; Ralf Sundberg; Ann Childers; Katharine Morrison; Anssi H Manninen; Hussain M Dashti; Richard J Wood; Jay Wortman; Nicolai Worm
Journal:  Nutrition       Date:  2014-07-16       Impact factor: 4.008

9.  The impact of telemedicine interventions involving routine transmission of blood glucose data with clinician feedback on metabolic control in youth with type 1 diabetes: a systematic review and meta-analysis.

Authors:  Rayzel M Shulman; Clodagh S O'Gorman; Mark R Palmert
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-22

Review 10.  Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.

Authors:  Ulrik Pedersen-Bjergaard; Saud Alsifri; Ronnie Aronson; Maja Cigrovski Berković; Gagik Galstyan; Helge Gydesen; Jesper Barner Lekdorf; Bernhard Ludvik; Erik Moberg; Ambady Ramachandran; Kamlesh Khunti
Journal:  Diabetes Obes Metab       Date:  2018-12-17       Impact factor: 6.577

View more
  1 in total

Review 1.  Electrospun nanofiber-based glucose sensors for glucose detection.

Authors:  Yutong Du; Xinyi Zhang; Ping Liu; Deng-Guang Yu; Ruiliang Ge
Journal:  Front Chem       Date:  2022-08-11       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.